MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof’s criteria but different lesion patterns-Reference-Cited by-同舟云学术

MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof’s criteria but different lesion patterns

Published:2009-03-01 Issue:7 Volume:256 Page:1121-1125
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Huttner Hagen B.,Schellinger Peter D.,Struffert Tobias,Richter Gregor,Engelhorn Tobias,Bassemir Teresa,Mäurer Mathias,Garcia Meritxell,Schwab Stefan,Köhrmann Martin,Doerfler Arnd

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-009-5081-y.pdf

Reference39 articles.

1. Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Gronning M et al (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897–902

2. Arnold DL, Matthews PM (2002) MRI in the diagnosis and management of multiple sclerosis. Neurology 58:S23–S31

3. Avasarala JR, Cross AH, Trotter JL (2001) Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol 58:2044–2045

4. Bakshi R, Hutton GJ, Miller JR, Radue EW (2004) The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis. Neurology 63:S3–S11

5. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ader HJ, Losseff N, Valk J (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120(Pt 11):2059–2069

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical applications of immunosequencing;Current Research in Translational Medicine;2024-09

2. Cerebrospinal fluid oligoclonal bands in Chinese patients with multiple sclerosis: the prevalence and its association with clinical features;Frontiers in Immunology;2023-11-16

3. Dual positivity for anti-MOG and oligoclonal bands: Unveiling unique clinical profiles and implications;Multiple Sclerosis and Related Disorders;2023-11

4. Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2022-01

5. Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers;International Journal of Molecular Sciences;2021-07-09